Leonteq Securities’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16K Hold
139
– – ﹤0.01% 1172
2026
Q2
$795 Hold
139
– – ﹤0.01% 1190
2026
Q1
$873 Hold
139
– – ﹤0.01% 1199
2025
Q4
$1.7K Hold
139
– – ﹤0.01% 1324
2025
Q3
$2.85K Buy
+139
New +$2.2K ﹤0.01% 1203
2023
Q2
– Sell
-304
Closed -$4.45K – 1291
2023
Q1
$4.45K Sell
304
-25
-8% -$418 ﹤0.01% 1106
2022
Q4
$5.53K Hold
329
– – ﹤0.01% 1126
2022
Q3
$4.88K Hold
329
– – ﹤0.01% 1131
2022
Q2
$9.01K Sell
329
-29
-8% -$859 ﹤0.01% 1097
2022
Q1
$13.5K Hold
358
– – ﹤0.01% 1065
2021
Q4
$22.2K Hold
358
– – ﹤0.01% 1024
2021
Q3
$30.6K Buy
+358
New +$22.5K ﹤0.01% 909

Other funds holding OPRX

Leonteq Securities's OPRX Position: Q3 2026 in Review

Leonteq Securities held its OptimizeRx (OPRX) position steady in Q3 2026 at 139 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Leonteq Securities first reported a position in OPRX in Q3 2021 and has held it in 12 quarters since. The position peaked at $30.6K in Q3 2021. 74 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • Leonteq Securities held 139 shares of OptimizeRx worth $1.16K as of Q3 2026.
  • Leonteq Securities left its OptimizeRx share count unchanged in Q3 2026.
  • OptimizeRx made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1172 holding.
  • Leonteq Securities first reported a position in OptimizeRx in Q3 2021 and has held it in 12 quarters since.
  • Leonteq Securities's OptimizeRx position peaked at $30.6K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.